Early Phase 1
N=30
Does Intravenous Lactated Ringer Solution Raise Measured Serum Lactate?
Hyperlactatemia
Bottom Line
View on ClinicalTrials.gov: NCT02950753 ↗Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Apr 2019
Primary outcome: Primary: Change in Mean Lactate Level of the LR Group Compared to the NS Group. — 0.93; 0.37 mmol/L
Study Design & Population
- Study type
- Interventional
- Phase
- Early Phase 1
- Interventions
- Lactated Ringer Solution (Drug); Normal Saline (Drug)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- University Medical Center of Southern Nevada
- Primary completion
- May 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Mean Lactate Level of the LR Group Compared to the NS Group. |
0.93; 0.37 | — |
| SECONDARY Decrease in Bicarbonate Level of the LR Group Compared to the NS Group |
-0.36; 2.35 | — |
| SECONDARY Final Chloride Level Minus Initial Chloride Level of the LR Group Compared to the NS Group |
-0.4; 3.7 | — |
Summary
Lactated Ringer's (LR) solution bolus is commonly administered in the emergency department setting to seriously ill patients. It is also common to obtain blood samples to determine serum lactate levels to aid in the assessment of the patient's degree of illness. This study endeavors to determine if serum lactate levels are affected by LR fluid administration in healthy adult individuals as compared to those who receive Normal Saline (NS). Healthy adult volunteers will be used as subjects so that the illness of hospital patients does not confound the results.
Eligibility Criteria
Inclusion Criteria
- Healthy adult volunteers
- 18 years and older
Exclusion Criteria
- Pregnancy or currently breast-feeding
- Prisoner
- History of conditions associated with fluid overload: heart, renal or hepatic failure
- Baseline serum lactate level >2.2mmol
- Baseline creatinine > 1.5 mg/dL
Data sourced from ClinicalTrials.gov (NCT02950753). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.